Patricia Ford, MD, a leader in bloodless medicine and transfusion-free oncology, discusses her career and how she became the ...

A new approach to using stem cell–derived pancreatic islets has allowed a patient with type 1 diabetes (T1D) to come off insulin for 1 year. The chemically induced pluripotent stem cell–derived islets ...

Stanford Medicine pediatric hematologist Agnieszka Czechowicz, MD, Ph.D., has devoted her research career to improving ...

The team, in collaboration with Shanghai Changzheng Hospital, has conducted regenerative islet transplantation surgeries using autologous and allogeneic stem cell-derived islets on three patients with ...

An antibody treatment developed at Stanford Medicine successfully prepared patients for stem cell transplants without toxic busulfan chemotherapy or radiation, a phase 1 clinical trial has shown.

After an allogeneic stem cell transplant, a recipient’s body faces a daunting task: rebuilding the person’s blood-forming and immune systems from the ground up from a relatively small number of “seed” ...

SYRACUSE, N.Y. (WSYR-TV) — A Central Square woman is turning one of her hardest battles of her life into a message of hope ...

Please provide your email address to receive an email when new articles are posted on . Research has shown that autologous hematopoietic stem cell transplantation is an effective treatment for MS. At ...

Juan Uribe shared an update on his search for a a stem cell donor match for his son, Max ...

Stem cell transplants remain essential for blood cancers, with expanded donor options including half-matched family members and umbilical cord blood. Cyclophosphamide has improved graft-versus-host ...

A radical stem cell transplant has significantly improved the blurry vision of three people with severe damage to their cornea. The clinical trial, which took place in Japan, is the first of its kind ...